The ESMO Colloquia are innovative new sessions within the Congress programme that bring together top experts to discuss evolving areas of interest to the oncology community.
The Colloquia are organised by ESMO and supported by the industry in a unique collaboration making them the perfect complement to the scientific and education programme of the congress.
Saturday, 18 November 2017
ESMO Colloquium: Selection criteria for the treatment of castration-resistant prostate cancer (CRPC)
Room 325, 12:45 – 14:15
This educational activity was provided by ESMO and supported by Astellas.
View the ESMO colloquium details
Learning Objectives
- Understand and optimise the use of available treatment
- Select the best treatment according to clinical presentation
- Consider tolerance profile and patient preferences
Sunday, 19 November 2017
ESMO Colloquium: The incoming wave of Oncology Biosimilars, in Asia
Hall 404, 11:00 – 12:30
This educational activity was provided by ESMO and supported by Amgen, Pfizer, Roche and Sandoz
View the ESMO colloquium details
Learning Objectives
- Understand the complexities and nuances of developing biosimilar medicinal products in the Asia-Pacific region
- Educate the Asia-Pacific community, especially prescribers, on biosimilar medical products in the field of oncology
- Assess the financial impact of biosimilar medicinal products in the Asia-Pacific region
- Discuss potential challenges the oncology community, including patients, may face and the possible solutions